Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors
View Patent ↗The present invention relates to a method of screening for a compound that regulate SUMOylation of the nuclear receptor proteins comprising contacting the compound of interest to the nuclear receptor protein, and detecting SUMOylation of the nuclear receptor protein, thereby screening for a compound that regulates SUMOylation.
1. A method of screening for a compound that regulates SUMOylation of a nuclear receptor protein comprising:
a. contacting the compound of interest to the nuclear receptor protein, and
b. detecting coupling of small ubiquitin-like modifier (SUMO) to the nuclear receptor protein, wherein the coupling of SUMO to the nuclear receptor protein in the presence of the compound of interest is indicative of the regulation of SUMOylation of the nuclear receptor protein by the compound of interest, wherein the nuclear receptor protein is selected from a group consisting of PPARγ, PPARα, PPARδ, LXRα and LXRβ,
thereby screening for a compound that regulates SUMOylation of a nuclear receptor protein.
2. The method of claim 1 , wherein the compound that regulates SUMOylation and inflammation and comprises a small molecule, a peptide, or a combination thereof.
3. The method of claim 1 , wherein SUMOylation is detected using co-immunoprecipitation.
4. A method of assaying SUMOylation of nuclear receptor proteins comprising the steps of claim 1 .
5. The method of claim 1 , wherein SUMOylation is detected by assaying transcriptional activation of a reporter gene, two-hybrid screens, fluorescence resonance energy transfer (FRET), enzyme-linked immunosorbent assay (ELISA), co-immunoprecipitation, Western blotting or chromatin immunoprecipitation.
6. The method of claim 1 , wherein the compound of interest induces SUMOylation of nuclear receptor proteins.